While investigating the biological function of TFPI-2 in breast cancer cells, we observed that breast cancer cells, either constitutively expressing TFPI-2 or stimulated with rTFPI-2, have decreased invasive ability that could be reversed by TFPI-2 down-regulation. This evidence concerns the gene TFPI2 and breast carcinoma.